investor.bg-medicine.com
Investors/news | BG Medicine, Inc.The Investor Relations website contains information about BG Medicine, Inc. business for stockholders, potential investors, and financial analysts.
http://investor.bg-medicine.com/
The Investor Relations website contains information about BG Medicine, Inc. business for stockholders, potential investors, and financial analysts.
http://investor.bg-medicine.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
PAGES IN
THIS WEBSITE
15
SSL
EXTERNAL LINKS
0
SITE IP
206.200.251.19
LOAD TIME
0 sec
SCORE
6.2
Investors/news | BG Medicine, Inc. | investor.bg-medicine.com Reviews
https://investor.bg-medicine.com
The Investor Relations website contains information about BG Medicine, Inc. business for stockholders, potential investors, and financial analysts.
investor.bg-medicine.com
Management | BG Medicine, Inc.
http://investor.bg-medicine.com/management.cfm
Paul R. Sohmer M.D. Executive Vice President, Chief Financial Officer. Aram Adourian Ph.D. Senior Vice President and Chief Scientific Officer. BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3 Test, is dedicated to developing and delivering innovative solutions for healthcare providers that provide insight and transform the clinical care of heart failure and related disorders. 303 Wyman Street • Suite 300. Waltham, MA 02451. 2016 BG Medicine, Inc.
Investors/news | BG Medicine, Inc.
http://investor.bg-medicine.com/index.cfm
BG Medicine, Inc. (OTCQB:BGMD), the developer of the BGM Galectin-3 Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. Dec 23, 2015. BG Medicine Withdraws 510(k) Premarket Notification for Proposed Additional Indication for the BGM Galectin-3 Test. Nov 30, 2015. License and Distribution Agreement Amended. View all press releases ». Nov 17, 2015 at 8:30 AM ET. BG Medicine, Inc. Business Update. Waltham, MA 02451.
Ownership Profile | BG Medicine, Inc.
http://investor.bg-medicine.com/ownership-profile.cfm
Ownership data is provided by Thompson Reuters, a third party service, and BG Medicine, Inc. does not maintain or provide information directly to this service. BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3 Test, is dedicated to developing and delivering innovative solutions for healthcare providers that provide insight and transform the clinical care of heart failure and related disorders. 303 Wyman Street • Suite 300. Waltham, MA 02451. 2016 BG Medicine, Inc.
Stock Information | BG Medicine, Inc.
http://investor.bg-medicine.com/stockquote.cfm
3:15 PM ET on Aug 26, 2016. The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by eSignal, stock charts are provided by EDGAR Online, both third party services, and BG Medicine, Inc. does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes. 303 Wyman Street • Suite 300. Waltham, MA 02451. 2016 BG Medicine, Inc.
Press Releases | BG Medicine, Inc.
http://investor.bg-medicine.com/releases.cfm
Dec 23, 2015. BG Medicine Withdraws 510(k) Premarket Notification for Proposed Additional Indication for the BGM Galectin-3 Test. WALTHAM, Mass., Dec. 23, 2015 (GLOBE NEWSWIRE) - BG Medicine, Inc. (OTCQB:BGMD) today announced that it has submitted to the FDA a notice of withdrawal of its 510(k) premarket notification filing with the US Food and Drug Administration ("FDA") that was submitted in order to obtain regulatory clearance to market its BGM Galectin-3 Test fo. File is in Briefcase. Nov 30, 2015.
TOTAL PAGES IN THIS WEBSITE
15
B/E Aerospace | Investor Relations | Overview
Reports and SEC Filings. Power to Deliver." data-text=". Access stock data, financial reports and shareholder services for B/E Aerospace, the world's leading manufacturer of cabin products for passenger aircraft. Access stock data, financial reports and shareholder services for B/E Aerospace, the world's leading manufacturer of cabin products for passenger aircraft. To download the B/E Aerospace / KLX Spin-off Stock Cost Basis Form 8937. In PDF format please click here. In PDF format please click here.
Belden Inc. - Investor Relations - Overview
Interactive Fundamentals span class=q4-icons q4-square-share /span. March 23, 2018. Belden Inc. Announces Redemption of Shareholder Rights Agreement. March 13, 2018. Belden Announces Expiration and Final Results of Its Tender Offers for Any and All of the Outstanding Senior Subordinated Notes Listed Below:. March 6, 2018. Belden Announces Pricing of 350 Million Private Offering of 3.875% Senior Subordinated Notes. February 1, 2018. Belden Fourth Quarter 2017 Earnings Results Conference Call.
Belmond Ltd. – Investor Relations
Skip to main content. Quarterly and Annual Reports. Stock Quote and Chart. The ultimate travel connoisseur,. Creating exceptional experiences worldwide. Belmond Ltd. is a global collection of exceptional hotel and luxury travel adventures in some of the world’s most inspiring and enriching destinations. Belmond Names Philippe Cassis as Chief Operating Officer. Register for our email alerts to receive Belmond Ltd. financial information via email. Vice President, Corporate Finance and Investor Relations.
Investor Relations | Benefitfocus
Benefitfocus FY15 Quarterly Results. 2nd Quarter 2015 Earnings Call Conference Call. Benefitfocus Announces Second Quarter 2015 Financial Results. Aug 12, 2015. Benefitfocus Announces Closing of Secondary Offering. Aug 11, 2015. Benefitfocus Publishes Inaugural Buyer's Guide to Effective Benefits Management Technology. Aug 7, 2015. Benefitfocus Announces Pricing of Secondary Offering. Aug 6, 2015. Benefitfocus to Present at the 35th Annual Canaccord Growth Conference. Aug 12, 2015 at 1:30 PM ET.
Investor.bg – Финанси, Бизнес, Имоти, Фондова борса, Валутна търговия
Петък, 30.03.2018. Централна и Източна Европа. Коментари за недвижими имоти. БФБ в реално време. Първи стъпки във Forex. Запомни ме на това устройство. Съгласен съм с условията за ползване. Готвената енергийна реформа ще трябва да бъде одобрена от ЕК. 57% от българите подозират участие на правителството в сделката за ЧЕЗ. Изкупените дългове в България могат да достигнат 1,5 млрд. лв. през 2018 г. Караниколов: Инвеститорите се завръщат в България. Финансова децентрализация през крив макарон. 2,74 1.37%.
Investors/news | BG Medicine, Inc.
BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3 Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. Jul 27, 2015. BG Medicine Welcomes U.S. Market Introduction of Automated Galectin-3 Test at the 2015 American Association for Clinical Chemistry Annual Meeting. Jul 15, 2015. BG Medicine Announces Payoff of Secured Term Loan. View all press releases ». May 14, 2015 at 8:30 AM ET.
B.Grimm Power Public Company Limited
Power Plants in Operation. Power Plants In Development. BGrimm turns up the power. AMATA B. GRIMM POWER. POWER PLANT INFRASTRUCTURE FUND. Subscribe to our newsletter. Tel : 66 (0) 2710 3400. Fax : 66 (0) 2379 4245. Email : IR@bgrimmpower.com.
DB Corp Ltd
11 States 46 Editions. 2 States 9 Editions. 1 State 6 Editions. 7 States 30 Cities. FAQs : Share Information. D B Corp Ltd. is engaged in printing and publication of Newspaper in four languages across 12 states 66 Editions, in Radio Business with "94.3 MY FM" in 7 states and 30 cities along with strong digital business presence with 13 portals and 2 Mobile App. Only print media conglomerate, in four multiple languages is a dominant player and enjoys leadership position in its all major markets. More than...
BID | Nhà đầu tư | BIDV Investor
Tìm kiếm nâng cao. Lịch sử phát triển. Ban lãnh đạo. Nhà đầu tư. Tin tức and Nhận định. Thông tin tài chính. Thông tin cổ đông. Quản trị doanh nghiệp. Sản phẩm and Dịch vụ. Khách hàng cá nhân. Khách hàng doanh nghiệp. Định chế tài chính. Tin tức and Nhận định. Giải bóng đá BIDV - Man Utd CUP. Thông cáo báo chí. Bản tin thị trường. Thông tin tài chính - ngân hàng. Hoạt động tài trợ vì cộng đồng. Bản đồ mạng lưới. VND) -100 (-0,6%). Vốn hóa (Tỷ VND). Biên bản và Nghị quyết ĐHĐCĐ bất thường 2016.
BiipBiip.dk Investor Center | Her kan alle være med
BiipBiip.dk Investor Center. Her kan alle være med. Velkommen til investor.biipbiip.dk. Her kan Du invester i BiipBiip.dk s projekter. Du kan endda blive bestyrelses medlem hvis du har købt nok andele læs mere om det, under hvert projekt. Seed kapital investor søges til projekter:. Investering fra 50 kr. Investering fra 75 kr. Investering fra 500 kr. Investering fra 300 kr. Investering fra 3000 kr.
BioAmber Inc. - Press Releases
Sarnia Plant Media Kit. Get News Alerts by Email. STAY IN TOUCH WITH VALUABLE INFORMATION. NYSE: BIOA STOCK INFORMATION. Select from the drop-down menu below to view the latest trading information on our common stock and warrants, which are both traded on the New York Stock Exchange (NYSE:BIOA and NYSE:BIOA.WS respectively). NYSE: BIOA STOCK INFORMATION. View all SEC filings. Q2 2015 Earnings Call. August 4, 2015. Raymond J. Land. Ellen B. Richstone. Kenneth W. Wall. The Company’s Board of Directors has ...
SOCIAL ENGAGEMENT